Skip to main content

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India...

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India... image

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal - Reuters

U.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.
Read More

In Similar Category

From Reuters